health
(Undated) — A cross-country storm is taking aim at the Southeast today. The Tennessee Valley and Southern Appalachians are expected to be hit the hardest, with main threat expected to be heavy rain and damaging wind gusts. Isolated tornadoes are also possible. States across the region like Tennessee, Alabama,...
Read More
The Media Line: Israeli Official Dismisses NYT Report on Iran Chemical Weapons Threat
Israeli Official Dismisses NYT Report on Iran Chemical Weapons Threat
By The Media Line Staff
A senior Israeli official said Wednesday that Iran currently has no chemical weapons capability threatening Israel, a day after The New York Times reported that Israeli...
Read More
CVS will split up its pharmacy and insurance business into two companies, WSJ says
By Sabrina Valle and Siddhi Mahatole
Nov 3 (Reuters) – CVS Health plans to break up its $117 billion business, separating its retail pharmacies from the Caremark pharmacy benefit management operations and the Aetna insurance company it bought nearly a decade ago, the Wall...
Read More
health Headlines
India proposes instant manufacturing licence suspension for drugs failing quality tests- British healthcare worker with Ebola to be evacuated from Congo to UK, document shows
- Red Cross delivers essential medical supplies to Yemen’s besieged Taiz city
- India’s Aurobindo Pharma’s quarterly profit rises by a third on strong US demand
- Health insurers, hospitals rally after sweeping midterm win for Democrats
- India’s Apollo Hospitals posts higher quarterly profit
- Health Rounds: GLP-1 drugs help control prediabetes better than current standard medicine
- Novo loses share in Brazil to cheaper generics, but holds up in Canada and India
- How CVS built a healthcare empire it now plans to split
- Swiss pharma industry behind in technology and clinical trials, index shows
- Bayer seeks bigger role in fast-growing Latin American biologicals market
- Chinese drugmaker Ganzhou Hemay delays Hong Kong listing on market conditions
- India’s Alembic Pharma profit jumps on strong US sales
- India’s Dr Lal PathLabs posts higher quarterly profit on strong diagnostic test demand
- Sino Biopharmaceutical, Boehringer ink cancer drug deal worth $7 billion in milestones
- India’s Zydus Lifesciences posts lower profit as expenses outpace revenue growth
- Smith+Nephew cuts outlook after failed orthopaedics deal talks with J&J
- Novo hikes outlook again as it speeds up Wegovy pill rollout
- Fresenius lifts 2026 expectations after strong Q3
- AbbVie expands Oxford R&D facility as part of £120 million-plus investment
- Nurix says Sanofi discontinues autoimmune disease drug program
- Merck gets US FDA emergency use nod for treatment of screwworm in dogs
- Amgen posts higher-than-expected third quarter results, but shares dip
- Food distributor Sysco says cyclosporiasis outbreak hit Q1 sales
- Teva Pharm to grow more in 2027 despite US’ IRA impact on Austedo
- Thousands of pregnant women at risk in Yemeni city of Taiz, UN agency says
- Teva profit beats forecasts, raises 2026 revenue estimates
- Kenya discharges five Ebola patients, no new cases reported
- Ebola survivors comfort sick children in Congo’s isolation wards
- Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive third-quarter results
- Coloplast pares back China operations as market recovery remains elusive
- Roundup settlement expected before Christmas, Bayer CEO says
- Bayer raises 2026 profit outlook as pharma business beats expectations
- Fresenius Medical cuts 2026 profit outlook as US treatment decline deepens
- Biomérieux third-quarter organic sales growth beats expectations
- Philips reaches DOJ agreement over device recall, books €288 million provision in Q3
- New York state reports first measles-linked child death in over 30 years amid outbreak
- The Media Line: Israel’s First Robotic Lung Transplant Could Cut Pain, Recovery Time
- Cerus’ blood-safety system meets main goal in late-stage trial
- Evidence of red blood cells seen in dinosaur fossil from Brazil
- Pennsylvania measles cases rise to 1,433, state health department says
- Dr Reddy’s gets tentative US FDA nod for generic HIV prevention
- IDEXX raises forecast, betting diagnostics can offset weak vet visits
- CT Senator Awake And Alert Following Stroke
- Teva to discontinue mid-stage neurodegenerative disorder study
- FDA to review uniQure’s Huntington’s gene therapy, decision due on May 2027
- Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target
- South Africa’s Aspen Pharmacare to sell women’s health product in Europe to Ennogen
- Tiziana’s experimental MS treatment meets main goals in mid-stage study
- Granules India profit surges as higher sales outweigh cost pressures
